ECMO治疗成人严重ARDS的系统性评价

1、1会计学ECMO治疗成人严重治疗成人严重ARDS的系统性评价的系统性评价 传统的治疗手段可以解决通气问题。能完全解决氧供问题吗？Hill JD, OBrien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ, Gerbode F. Prolonged extracorporeal oxygenation for acute posttraumatic respiratory failure (shock-lung syndrome): use of the Bramson membrane lung. N Engl J Med 1972;286

2、(12):629634. ECMO的原理的原理 RESPIRATORY CARE JULY 2004 VOL 49 NO 7我们检索结果我们将“ECMO and ARDS”作为关键词检索结果如下：1、 PUBMED：检索到相关文献326篇2、 SCI和 Cochrane Library：检索结果均为0。3、 EMBASE：检索到相关文献5篇。4、 中国生物医学文献数据库(CBMDISC) ：49篇。AuthorLanguageResearchtypeNecmo/Mt(all)PatientsMortalityJournalBeiderlinden M.Germany/Englishu n c

3、o n t r o l l e dProspective32/118(150)PA-ARDS46.9/28.8%,p =0.059IntensiveCareMed.2006Jul28;Henzler DGermany/Germanu n c o n t r o l l e dProspective/(93)ARDS33%(30%)Anaesthesist.2004Mar;53(3):235-43.Mols GGermany/Germanu n c o n t r o l l e dProspective62/183(245)ARDS45%/39%()AnasthesiolIntensivmed

4、NotfallmedSchmerzther.2001Jan;36(1):4-14.Lewandowski KGerman/Englishuncontrolledprospectivetrial.49/73(122)ARDS45%/11%(25%)IntensiveCareMed.1997Aug;23(8):819-35.Manert WGermany/Germanuncontrolledprospective(routinetreatment/slowentry/fastentry39RT/10SRECMO/11FRECMO(60)ARDS23%/40%/0Anaesthesist.1996M

5、ay;45(5):437-48.Morris AHUSA /EnglishRandomized Controlled Trial 21 / 19(40) ARDS 67%/58%(62%) p = 0.8 Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):295-305. Zapol WM,USA/EnglishRandomized Controlled Trial42/48(90)ARDS90.5%/91.7%JAMA.1979Nov16;242(20):2193-6.Prospective trialsProspective trialsAut

6、horLanguageResearchtypeNecmo/mv(all)PatientsMortalityJournalBeiderlinden M.Germany/Englishu n c o n t r o l l e dProspective32/118(150)PA-ARDS46.9/28.8%,p =0.059IntensiveCareMed.2006Jul28;Henzler DGermany/Germanu n c o n t r o l l e dProspective/(93)ARDS33%(30%)Anaesthesist.2004Mar;53(3):235-43.Mols

7、 GGermany/Germanu n c o n t r o l l e dProspective62/183(245)ARDS45%/39%()AnasthesiolIntensivmedNotfallmedSchmerzther.2001Jan;36(1):4-14.Lewandowski KGerman/Englishuncontrolledprospective.49/73(122)ARDS45%/11%(25%)IntensiveCareMed.1997Aug;23(8):819-35.Manert WGermany/Germanuncontrolledprospective(ro

8、utinetreatment/slowentry/fastentry39RT/10SRECMO/11FRECMO(60)ARDS23%/40%/0Anaesthesist.1996May;45(5):437-48.Morris AHUSA /EnglishRandomized Controlled Trial 21 / 19(40) ARDS 67%/58%(62%) p = 0.8 Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):295-305. Zapol WM,USA/EnglishRandomized Controlled Trial42

9、/48(90)ARDS90.5%/91.7%JAMA.1979Nov16;242(20):2193-6.Prospective trialsProspective trialsAuthorLanguageResearchtypeNecmo/mv(all)PatientsMortalityecmo/mv(all)JournalBeiderlinden M.Germany/Englishu n c o n t r o l l e dProspective32/118(150)PA-ARDS46.9/28.8%,p =0.059IntensiveCareMed.2006Jul28;Henzler D

10、Germany/Germanu n c o n t r o l l e dProspective/(93)ARDS33%(30%)Anaesthesist.2004Mar;53(3):235-43.Mols GGermany/Germanu n c o n t r o l l e dProspective62/183(245)ARDS45%/39%()AnasthesiolIntensivmedNotfallmedSchmerzther.2001Jan;36(1):4-14.Lewandowski KGerman/Englishuncontrolledprospective.49/73(122

11、)ARDS45%/11%(25%)IntensiveCareMed.1997Aug;23(8):819-35.Manert WGermany/Germanuncontrolledprospective(routinetreatment/slowentry/fastentry39RT/10SRECMO/11FRECMO(60)ARDS23%/40%/0Anaesthesist.1996May;45(5):437-48.Morris AHUSA /EnglishRandomized Controlled Trial 21 / 19(40) ARDS 67%/58%(62%) p = 0.8 Am J Respir Crit Care Med. 1994